Status:
UNKNOWN
Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
Lead Sponsor:
Munich Municipal Hospital
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40-80 years
Phase:
PHASE4
Brief Summary
Compared to human insulins analogue insulins offer the option of optimizing metabolism also in type 2 diabetes. Especially, fast acting insulin analogues lower postprandial glucose levels more effecti...
Detailed Description
This is a single centre, long term (24-48 months), therapy controlled and randomised study with blinded analysis of the ultrasound data in 120 patients with type 2 diabetes mellitus and with previous ...
Eligibility Criteria
Inclusion
- type 2 diabetes, insulin therapy
Exclusion
- type 1 diabetes, BMI \>40, pregnancy,
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00747409
Start Date
July 1 2004
End Date
June 1 2009
Last Update
September 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Staedt. Klinikum Muenchen Bogenhausen
Munich, Bavaria, Germany, 81925